Showing results (31-40 of 52) with videos related to
Sort By:
Pageof 6
The Journal of Infectious Diseases|February 18, 2005
TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancerAlina Deshpande, John P Nolan, P Scott White, et al.The Journal of Infectious Diseases|February 6, 2008
Variation in HLA class I antigen-processing genes and susceptibility to human papillomavirus type 16-associated cervical cancerAlina Deshpande, Cosette M Wheeler, William C Hunt, et al.JAMA Oncology|June 28, 2017
Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus TestingJack Cuzick, Orrin Myers, Ji-Hyun Lee, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2013
A population-based evaluation of cervical screening in the United States: 2008-2011Jack Cuzick, Orrin Myers, William C Hunt, et al.Journal of General Internal Medicine|October 3, 2003
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes studyRichard M Hoffman, Linda C Harlan, Carrie N Klabunde, et al.International Journal of Cancer|December 3, 2014
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical managementJack Cuzick, Orrin Myers, William C Hunt, et al.International Journal of Cancer|April 26, 2012
A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccinationCosette M Wheeler, William C Hunt, Jack Cuzick, et al.Annals of Internal Medicine|September 29, 2015
Inefficiencies and High-Value Improvements in U.S. Cervical Cancer Screening Practice: A Cost-Effectiveness AnalysisJane J Kim, Nicole G Campos, Stephen Sy, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 1, 2015
Risk Stratification Using Human Papillomavirus Testing among Women with Equivocally Abnormal Cytology: Results from a State-Wide Surveillance ProgramJulia C Gage, William C Hunt, Mark Schiffman, et al.Journal of Virology|July 5, 2002
Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccineRebecca T Emeny, Cosette M Wheeler, Kathrin U Jansen, et al.Pageof 6